硫酸卷曲霉素
硫酸卷曲霉素结构式
|
常用名 | 硫酸卷曲霉素 | 英文名 | Capreomycin Sulfate |
|---|---|---|---|---|
| CAS号 | 1405-37-4 | 分子量 | 750.78 | |
| 密度 | N/A | 沸点 | 1376.7ºC at 760mmHg | |
| 分子式 | C25H46N14O11S | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 786.4ºC | |
| 符号 |
GHS07, GHS08 |
信号词 | Danger |
|
Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.
Microb. Drug Resist. 21 , 292-6, (2015) A total of 92 Mycobacterium tuberculosis isolates were collected from patients with pulmonary tuberculosis (TB) in the Zunyi region between 2011 and 2012. Collected isolates were used to determine antibiotic susceptibility patterns against 13 anti-TB drugs: 4... |
|
|
Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
Antimicrob. Agents Chemother. 55 , 4712 - 4717, (2011) Capreomycin and the structurally similar compound viomycin are cyclic peptide antibiotics which are particularly active against Mycobacterium tuberculosis, including multidrug resistant strains. Both antibiotics bind across the ribosomal interface involving 2... |
|
|
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Antimicrob. Agents Chemother. 49 , 571-577, (2005) Capreomycin, an important drug for the treatment of multidrug-resistant tuberculosis, is a macrocyclic peptide antibiotic produced by Saccharothrix mutabolis subspecies capreolus. The basis of resistance to this drug was investigated by isolating and characte... |
|
|
A physiologically based pharmacokinetic model for capreomycin.
Antimicrob. Agents Chemother. 56 , 926-934, (2012) The emergence of multidrug-resistant tuberculosis (MDR-TB) has led to a renewed interest in the use of second-line antibiotic agents. Unfortunately, there are currently dearths of information, data, and computational models that can be used to help design rat... |
|
|
Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
J. Med. Assoc. Thai. 96(10) , 1273-82, (2013) Multi-drug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB) becomes an increasing problem in management. Linezolid has been off-label used in treatment of MDR/XDR-TB with major adverse effects.To study outcomes of MDR/XDR-TB patients treated wit... |